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Introduction: The diagnosis of peripheral arterial disease (PAD) can be made by measuring 
the ankle–brachial index (ABI). Traditionally ABI values . 1.00–1.40 have been considered 
normal and ABI # 0.90 defines PAD. Recent studies, however, have shown that individuals 
with ABI values between 0.90–1.00 are also at risk of cardiovascular events. We studied this 
cardiovascular risk population subgroup in order to determine their endothelial function using 
peripheral arterial tonometry (PAT).
Methods: We selected 66 individuals with cardiovascular risk and borderline ABI. They all 
had hypertension, newly diagnosed glucose disorder, metabolic syndrome, obesity, or a ten year 
risk of cardiovascular disease death of 5% or more according to the Systematic Coronary Risk 
Evaluation System (SCORE). Subjects with previously diagnosed diabetes or cardiovascular 
disease were excluded. Endothelial function was assessed by measuring the reactive hyperemia 
index (RHI) from fingertips using an Endo-PAT device.
Results: The mean ABI was 0.95 and mean RHI 2.11. Endothelial dysfunction, defined as 
RHI , 1.67, was detected in 15/66 (23%) of the subjects. There were no statistically significant 
differences in RHI values between subjects with different cardiovascular risk factors. The only 
exception was that subjects with impaired fasting glucose (IFG) had slightly lower RHI values 
(mean RHI 1.91) than subjects without IFG (mean RHI 2.24) (P = 0.02).
Conclusions: In a cardiovascular risk population with borderline ABI nearly every fourth 
subject had endothelial dysfunction, indicating an elevated risk of cardiovascular events. This 
might point out a subgroup of individuals in need of more aggressive treatment for their risk 
factors.
Keywords: peripheral arterial disease, ankle–brachial index, cardiovascular risk, endothelial 
dysfunction
Introduction
Peripheral arterial disease (PAD) is a manifestation of atherosclerosis in the lower 
limbs. It can be diagnosed by measuring the ankle–brachial index (ABI). A value 
of #0.90 determines PAD with a sensitivity of 95%, and a specificity of almost 100%.1 
  Traditionally normal ABI is considered as having a value of .1.00.2 ABI values between 
0.90 and 1.00 are also associated with an inversely related risk of cardiovascular 
  outcomes.3 Therefore individuals with so called “borderline ABI” have an elevated 
risk of cardiovascular events.4 Their risk is lower than in patients with PAD, but still 
significant, and they have increased risk of developing PAD without interventions.5
Although endothelium is constructed from a monolayer of rather simple cells, it 





cardiovascular disease is well established and   individuals 
with endothelial dysfunction have an increased risk of 
  cardiovascular events.6,7 Since the identification of nitric 
oxide, many different methods have been used to detect 
endothelial function, but due to logistical limitations their 
routine use in risk detection has been low.8 The gold standard 
technique is flow-mediated dilation (FMD) of the brachial 
artery.9,10 Novel digital pulse amplitude tonometry (PAT) 
offers the possibility of an easy and rapid assessment of 
vascular function.11–13 Recently it has been demonstrated that 
abnormalities in pulse wave amplitude are correlated with 
flow mediated dilatation measurement results.12
We used this novel method to determine the prevalence 
of endothelial dysfunction in a cardiovascular risk population 
with borderline ABI.
Materials and methods
The present study is a sub-study of the Harmonica project, 
and a detailed description of the enrolment and   examination 
methods has been published earlier.14 In the Harmonica project 
we measured the ABI of 972 individuals with newly diagnosed 
hypertension, glucose disorders, metabolic syndrome, obesity, 
or a ten year risk of cardiovascular disease death of 5% or more 
according to the Systematic Coronary Risk Evaluation System 
(SCORE). None of them had been previously diagnosed with 
cardiovascular disease or diabetes before participating in the 
Harmonica project. In this study we selected 66 individuals 
with borderline ABI and measured their endothelial function 
using PAT. This was a small sample population to test this 
novel methodology in this setting in the preliminary study.
ABI was measured using a blood pressure cuff and a 
Doppler instrument (UltraTec® PD1v with a 5 MHz vascular 
probe, United Kingdom) with the subject in a supine   position. 
We measured the systolic blood pressure (SBP) of the left 
and right brachial arteries in the upper arms. In the lower 
limbs, both the dorsalis pedis arterial pressure and posterior 
tibial arterial pressure were measured if available. The cuff 
was placed just above the level of the malleoli. A trained 
nurse performed all measurements. The ABI was the higher 
SPB of the lower limbs divided by the higher of the brachial 
SBPs. Participants who had an ABI value of #0.90 in either 
leg were categorized as having PAD. Subjects with an ABI 
value of between 0.91 and 1.00 were considered as borderline 
PAD. ABI . 1.00–1.40 was considered normal.
Endothelial function was assessed using a Endo-PAT 
device (Itamar Medical Ltd, Caesarea, Israel). During the 
measurement the subject sat in a chair with their hands at 
the level of their heart and fingers hanging freely. Fingertip 
probes were placed on both index fingers and pulse wave 
amplitudes were detected and recorded during the study. 
After a five-minute baseline measurement, arterial flow was 
occluded using a cuff on the non-dominant arm. The cuff 
was inflated to 40 mmHg above systolic pressure. After five 
minutes of occlusion, the cuff was rapidly deflated to allow 
reactive hyperemia. Pulse wave amplitudes were recorded 
again for at least five minutes. The software provided by the 
manufacturer was then used to compare the arterial pressure 
ratio in the two fingers before and after occlusion. It then cal-
culated a reactive hyperemia index (RHI), which was a ratio of 
the average pulse wave amplitude measured over 60 seconds, 
starting one minute after cuff deflation, to the average pulse 
wave amplitude measured at the baseline. The other arm 
served as a control and the ratio was corrected for changes in 
the systemic vascular tone. An RHI value of ,1.67 was used 
as a cut-off value to diagnose endothelial dysfunction.13
Statistical analysis
The statistical significance of differences between frequency 
distributions was tested using the Pearson’s χ2 test. The 
  difference between mean values was tested using the pairwise 
t-test or the Wilcoxon rank sum test for two samples. The 
normality of residuals was tested with the Shapiro–Wilks 
test, and if residuals were not normally distributed the 
  difference between RHI values was tested using the Wilcoxon 
test. P-values of less than 0.05 were considered statistically 
significant. The statistical analyses were carried out using 
SAS/STAT (r) software, Version 9.2 of the SAS System for 
Windows (SAS Institute Inc, Cary, NC, USA).
All of the participants provided written informed consent 
for the project and subsequent medical research. The study 
protocol and consent forms were reviewed and approved by 
the ethics committee of Satakunta Hospital District.
Results
The mean age in this study group was 60.1 years (50–75). 
We studied 66 subjects, 26 (39%) were males and 40 (61%) 
females. Ten (15%) were current smokers and 21 (32%) 
  former smokers. Hypertension was diagnosed in 35   individuals 
(55%), 27 (41%) had impaired fasting glucose (IFG), 22 (33%) 
impaired glucose tolerance (IGT), and six were diabetics (9%) 
(Table 1). More than one cardiovascular risk factor was found 
in 36 subjects (55%).
The mean (SD) ABI was 0.95 (0.023) and the mean 




cardiovascular risk population with borderline ABi
as RHI , 1.67, was detected in 15/66 (23%). When we 
  compared the RHI values of subjects with different risk 
factors, no statistically significant differences were found. 
The only exception was that subjects with IFG had slightly 
lower RHI values (mean RHI 1.91) than subjects without 
IFG (mean RHI 2.24) (Table 2).
Discussion
The endothelium plays an important role in the regulation 
of vascular tone and structure as first recognized by the 
experiments of Robert Furchgott’s group.15 The endothelium 
is also a target of vascular inflammation and thrombosis, 
the key events of the atherosclerotic disease process and 
its clinical implications, such as myocardial infarction and 
stroke. With the presence of cardiovascular risk factors such 
as hypercholesterolemia, hypertension, and smoking, the 
endothelium has reduced nitric oxide availability, impairing 
its function and endothelium-dependent vasodilation.16 This 
endothelial dysfunction is associated with a risk of major 
cardiovascular events.17 In the study carried out by Hamburg 
et al (2008), male sex, body mass index, ratio of total to high 
density lipoprotein cholesterol, diabetes mellitus, smoking, 
and lipid-lowering treatment were inversely related to the 
PAT ratio.18 An improvement in endothelial function and a 
reduction in the risk of vascular events can be achieved by 
intensively treating risk factors such as hypertension.19–21
For decades, ABI has been used as a tool of vascular 
practice to quantify the severity of occlusive disease among 
patients with leg symptoms, and to decide the need for 
  vascular interventions. More recently the role of ABI has been 
expanded, as it is a marker of cardiovascular risk. A normal 
ABI value is between 1.00–1.40 and PAD is defined as an 
ABI value of 0.90 or less. ABI . 1.40 might indicate medial 
sclerosis. The presence of an abnormal ABI value increases 
the risk of myocardial infarction and death, among other 
adverse outcomes.5,22,23 In the Walking and Leg Circulation 
Study (WALCS), subjects with low normal (ABI 1.00–1.09) 
and borderline PAD (ABI 0.90–0.99) also had a significant 
risk of mobility loss during follow up.24 The likely mechanism 
was progression towards PAD. We have previously shown 
that almost a third of hypertensive patients without known 
diabetes or prior cardiovascular or renal diseases have asymp-
tomatic PAD or borderline PAD.25 These results force us to 
rethink the optimal interpretation of ABI in vascular practices, 
and to start interventions early enough.
We studied a cardiovascular risk population that had not 
been previously diagnosed with diabetes or cardiovascular 
or renal diseases. We took a small sample of subjects with 
borderline ABI to evaluate the prevalence of endothelial 
dysfunction in this group and to test the methodology. To our 
knowledge this is the first study in this kind of setting. The 
homogenous nature of this group may be the main reason 
why we did not find differences in RHI values between 
different types of risk-factors (ie, all subjects had at least 
one cardiovascular risk factor). We used the cut-off value 
RHI , 1.67, determined in previous studies, to diagnose 
endothelial dysfunction.26–28 Almost every fourth subject 
with borderline ABI had endothelial dysfunction. This may 
point to a subgroup of patients who need intensive risk factor 
management in order to prevent cardiovascular events and 
loss of mobility.
Table 1 characteristics of the study subjects
Mean age (range) years 60.1 (50–75)
Males (%) 26 (39)
Females (%)  40 (61)
current smoker (%) 10 (15)
Former smoker (%) 21 (32)
Hypertension (%) 35 (55)
iFg (%) 27 (41)
igT (%) 22 (33)
T2DM (%) 6 (9)
Mean ABi (SD) 0.95 (0.023)
Mean RHi (SD) 2.11 (0.552)
endothelial dysfunction (%) 15 (23) 
Abbreviations:  ABi,  ankle–brachial  index;  iFg,  impaired  fasting  glucose;  igT, 
impaired glucose tolerance; RHi, reactive hyperemia index.
Table 2 comparison between subjects with different risk factors and RHi values
Risk factor Number of subjects 
with risk factor
Mean RHI (SD)  
(risk factor)
Mean RHI (SD) 
(no risk factor)
P-value
igT and/or iFg and/or T2DM 55 1.91 (0.332) 2.25 (0.587) 0.16
T2DM 6 1.79 (0.156) 2.14 (0.568) 0.14
igT 22 2.13 (0.390) 2.08 (0.632) 0.30
iFg 27 1.91 (0.397) 2.24 (0.608) 0.02a
Hypertension 35 2.04 (0.441) 2.18 (0.656) 0.70
Smoking 10 2.04 (0.643) 2.12 (0.531) 0.62
aStatistically significant.





PAT testing is free of operator dependent errors, because 
results are analyzed with a computerized, automated 
  algorithm. The observations can be considered as being free 
of subjective bias when compared to flow mediated dila-
tion measurements with ultrasound from brachial   arteries. 
This reliability is the strength of the method we used. 
In contrast, the reproducibility of the ABI measurements 
can be questioned if they are performed by inexperienced 
personnel. In the study carried out by Mätzke et al (2003), 
16% of ABI values differed by 0.15 or more from the median 
when measurements were taken by doctors with little or no 
  instructions.29 They concluded that to obtain reproducibility 
and quantitative measurement values, the measurements have 
to be performed by trained personnel. Our measurements 
were taken by a trained nurse. There is also a so-called center 
effect when ABI is measured with a sphygmomanometer and 
a Doppler probe but not with a semiautomatic device.30 This 
should be taken into account when planning multi-center 
studies based on ABI measurement.
Although the PAT results are free of intra- and inter-
observer variation, this method may be influenced by changes 
in the physiological state of the study subject. We made all 
the measurements in a controlled environment, including a 
quiet, darkened room at a steady room temperature. The other 
arm served as an internal control. Because dietary intake may 
influence the results, all the measurements were taken with 
the subject in a fasting state.31,32 Obviously a small number of 
study subjects can be considered as a limitation to our study, 
but the study group is a representative sample of people at 
cardiovascular risk in the general population.
Now that there is growing evidence to link low RHI scores 
and the risk of cardiovascular disease, it is encouraging that 
we can use this non-invasive method to provide an additional 
level of risk stratification to initiate early and aggressive treat-
ments to prevent future cardiovascular events. As pointed out 
by Celermajer (2008), the exact role of PAT in this regard is 
not clear, but there is evidence that it gives relevant predictive 
and prognostic data about endothelial function.33 However, 
the prognostic usefulness of this technique in clinical practice 
is only beginning to emerge. The technique per se is suitable 
for clinical use because it is reasonably priced, non-invasive 
and it requires minimal training. In the future it will be neces-
sary to perform large-scale clinical studies to provide us with 
further information about the diagnostic usefulness of PAT 
in everyday clinical practice. There might still be unknown 
factors to be discovered that influence PAT measurements 
and their results. Some clinical studies are currently under 
way and we can expect results in the near future.
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